Tag:
Cytomedix
Latest Headlines
Latest Headlines
Cytomedix snaps up stem cell biotech Aldagen for a bargain price
Just 10 months after abandoning its second effort to go public, Aldagen is selling out to a small regenerative medicine company for just $16 million in shares and the chance to earn another chunk of
Cytomedix gets $13M in RDO
Cytomedix says it has landed approximately $13 million in current and future funding via a registered direct offering and commitments under two separate equity purchase agreements. The company is
